Analysis Article • Jul 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJul 19, 2026
DataAggregated Company Financials
Companies6
- 7D-1.0%
- 3M-26.2%
- 1Y-25.9%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 1.0%, driven by Alibaba Health Information Technology declining 3.2%. On the other hand Fangzhou is actually up 9.5%. Overall the industry is down 26% in 12 months. Earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 Jul 2026 | HK$192.3b | HK$143.1b | HK$8.7b | 30.3x | 22.1x | 1.3x |
| Tue, 16 Jun 2026 | HK$199.8b | HK$143.1b | HK$8.7b | 34.1x | 22.9x | 1.4x |
| Thu, 14 May 2026 | HK$255.1b | HK$141.2b | HK$8.7b | 41.7x | 29.4x | 1.8x |
| Sat, 11 Apr 2026 | HK$270.3b | HK$140.4b | HK$8.6b | 46.6x | 31.3x | 1.9x |
| Mon, 09 Mar 2026 | HK$269.8b | HK$139.1b | HK$7.7b | 37.9x | 35.1x | 1.9x |
| Wed, 04 Feb 2026 | HK$332.4b | HK$128.8b | HK$6.9b | 46.8x | 48.2x | 2.6x |
| Fri, 02 Jan 2026 | HK$296.5b | HK$127.3b | HK$6.8b | 38x | 43.5x | 2.3x |
| Sun, 30 Nov 2025 | HK$324.8b | HK$125.9b | HK$6.7b | 42.4x | 48.2x | 2.6x |
| Tue, 28 Oct 2025 | HK$339.1b | HK$122.4b | HK$6.2b | 62.3x | 55.1x | 2.8x |
| Thu, 25 Sep 2025 | HK$373.9b | HK$122.2b | HK$6.1b | 68x | 60.9x | 3.1x |
| Sat, 23 Aug 2025 | HK$341.3b | HK$121.7b | HK$5.2b | 56.9x | 65.8x | 2.8x |
| Mon, 21 Jul 2025 | HK$260.1b | HK$115.3b | HK$4.5b | 48.4x | 57.7x | 2.3x |
| Wed, 18 Jun 2025 | HK$237.6b | HK$115.3b | HK$4.5b | 48.5x | 52.8x | 2.1x |
| Fri, 16 May 2025 | HK$233.7b | HK$111.8b | HK$4.2b | 64.5x | 55.4x | 2.1x |
| Sun, 13 Apr 2025 | HK$208.4b | HK$110.0b | HK$4.1b | 58.3x | 50.2x | 1.9x |
| Tue, 11 Mar 2025 | HK$227.1b | HK$107.6b | HK$5.3b | 48.3x | 43.2x | 2.1x |
| Thu, 06 Feb 2025 | HK$174.5b | HK$104.0b | HK$3.6b | 40.4x | 48.5x | 1.7x |
| Sat, 04 Jan 2025 | HK$147.6b | HK$103.3b | HK$3.6b | 35.3x | 41.3x | 1.4x |
| Mon, 02 Dec 2024 | HK$170.7b | HK$104.4b | HK$3.6b | 38.7x | 47.2x | 1.6x |
| Wed, 30 Oct 2024 | HK$176.6b | HK$104.4b | HK$3.3b | 50x | 53.4x | 1.7x |
| Fri, 27 Sep 2024 | HK$177.8b | HK$106.3b | HK$3.4b | 48.6x | 52.7x | 1.7x |
| Sun, 25 Aug 2024 | HK$132.3b | HK$104.9b | HK$3.3b | 36.3x | 39.8x | 1.3x |
| Tue, 23 Jul 2024 | HK$139.8b | HK$101.8b | HK$2.4b | 42.9x | 58.6x | 1.4x |
| Thu, 20 Jun 2024 | HK$156.1b | HK$102.0b | HK$2.4b | 47.4x | 65.3x | 1.5x |
| Sat, 18 May 2024 | HK$170.5b | HK$103.6b | HK$2.3b | 50.7x | 73.3x | 1.6x |
| Mon, 15 Apr 2024 | HK$139.7b | HK$103.9b | HK$2.3b | 41.8x | 59.9x | 1.3x |
| Wed, 13 Mar 2024 | HK$178.9b | HK$105.4b | -HK$1,459,930,676.70 | 59.2x | -122.5x | 1.7x |
| Fri, 09 Feb 2024 | HK$163.3b | HK$106.2b | -HK$1,472,215,305.64 | 53.1x | -110.9x | 1.5x |
| Sun, 07 Jan 2024 | HK$188.5b | HK$105.8b | -HK$1,465,349,501.00 | 58.4x | -128.6x | 1.8x |
| Tue, 05 Dec 2023 | HK$202.6b | HK$105.8b | -HK$1,466,665,351.00 | 63.8x | -138.1x | 1.9x |
| Thu, 02 Nov 2023 | HK$204.6b | HK$101.8b | -HK$1,734,930,984.00 | 85.4x | -117.9x | 2x |
| Sat, 30 Sep 2023 | HK$230.3b | HK$102.5b | -HK$1,677,826,260.00 | 101.5x | -137.3x | 2.2x |
| Mon, 28 Aug 2023 | HK$233.4b | HK$102.2b | -HK$1,954,934,659.00 | 75x | -119.4x | 2.3x |
| Wed, 26 Jul 2023 | HK$279.8b | HK$96.7b | -HK$4,196,547,026.00 | 122.6x | -66.7x | 2.9x |
Price to Earnings Ratio
-66.7x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.1x which is lower than its 3-year average PE of 98.5x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 0.25% | |
| Consumer Staples | 4.16% | |
| Food and Staples Retail | 0.32% | |
| Drug Retail | -1.01% | |
| Big Box Super Stores | 7.22% | |
| Food Retail | 2.12% | |
| Food Distributors | -3.12% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6086 Fangzhou | HK$0.81 | 9.5% +HK$97.0m | -79.0% | PE82x | |
| 314 Sipai Health Technology | HK$1.47 | 6.5% +HK$66.1m | -77.2% | PS0.5x |